相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Phase I study of escalating doses of carfilzomib with HyperCVAD in patients with newly diagnosed acute lymphoblastic leukemia
Brian A. Jonas et al.
AMERICAN JOURNAL OF HEMATOLOGY (2021)
Hypoxia favors chemoresistance in T-ALL through an HIF1α-mediated mTORC1 inhibition loop
Lucine Fahy et al.
BLOOD ADVANCES (2021)
Adrenergic Modulation of Hematopoiesis
Georges J. M. Maestroni
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2020)
Imaging and spatial analysis of hematopoietic stem cell niches
Alvaro Gomariz et al.
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2020)
HIF-1α is over-expressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia
Valentina Griggio et al.
HAEMATOLOGICA (2020)
New biomarkers and therapeutic strategies in acute lymphoblastic leukemias: Recent advances
Carolina Simioni et al.
HEMATOLOGICAL ONCOLOGY (2020)
Nanoparticles for Manipulation of the Developmental Wnt, Hedgehog, and Notch Signaling Pathways in Cancer
D. M. Valcourt et al.
ANNALS OF BIOMEDICAL ENGINEERING (2020)
Tumor angiogenesis: causes, consequences, challenges and opportunities
Roberta Lugano et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2020)
Treatment of children with relapsed and refractory acute lymphoblastic leukemia with mitoxantrone, vincristine, pegaspargase, dexamethasone, and bortezomib
Keith J. August et al.
PEDIATRIC BLOOD & CANCER (2020)
Delivery across the blood-brain barrier: nanomedicine for glioblastoma multiforme
Lynn Jena et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2020)
Glucocorticoids paradoxically facilitate steroid resistance in T cell acute lymphoblastic leukemias and thymocytes
Lauren K. Meyer et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Targeting signalling pathways and the immune microenvironment of cancer stem cells - a clinical update
Joseph A. Clara et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
miRNAs as Influencers of Cell-Cell Communication in Tumor Microenvironment
Ilaria Conti et al.
CELLS (2020)
Can VEGFR-3 be a better tumor marker for breast cancer than CA 15-3?
Monika Zajkowska et al.
ACTA BIOCHIMICA POLONICA (2020)
Biology and Treatment Paradigms in T Cell Acute Lymphoblastic Leukemia in Older Adolescents and Adults
Anand A. Patel et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2020)
Anti-leukemic effects of histone edeacetylase (HDAC) inhibition in acute lymphoblastic leukemia (ALL) cells: Shedding light on mitigating effects of NF-κB and autophagy on panobinostat cytotoxicity
Mahdieh Mehrpouri et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Characterizing Lymphangiogenesis and Concurrent Inflammation in Adipose Tissue in Response to VEGF-D
Adri Chakraborty et al.
FRONTIERS IN PHYSIOLOGY (2020)
Cancer Stem Cells-Origins and Biomarkers: Perspectives for Targeted Personalized Therapies
Lia Walcher et al.
FRONTIERS IN IMMUNOLOGY (2020)
SAMHD1 is a key regulator of the lineage-specific response of acute lymphoblastic leukaemias to nelarabine
Tamara Rothenburger et al.
COMMUNICATIONS BIOLOGY (2020)
Notch Signaling Function in the Angiocrine Regulation of Tumor Development
Alexandre Trindade et al.
CELLS (2020)
Distinct macrophage phenotypes skewed by local granulocyte macrophage colony-stimulating factor (GM-CSF) and macrophage colony-stimulating factor (M-CSF) are associated with tissue destruction and intimal hyperplasia in giant cell arteritis
William F. Jiemy et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2020)
Bone marrow niches in haematological malignancies
Simon Mendez-Ferrer et al.
NATURE REVIEWS CANCER (2020)
Clinical Pharmacokinetics and Pharmacodynamics of Bortezomib
Carlyn Rose C. Tan et al.
CLINICAL PHARMACOKINETICS (2019)
Leukemia-derived exosomes and cytokines pave the way for entry into the brain
Ichiko Kinjyo et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2019)
Inhibition of the PI3K/AKT signaling pathway sensitizes diffuse large B-cell lymphoma cells to treatment with proteasome inhibitors via suppression of BAG3
Ting Yuan et al.
ONCOLOGY LETTERS (2019)
Relapsed T Cell ALL: Current Approaches and New Directions
Christine M. McMahon et al.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2019)
Targeting mTOR in Acute Lymphoblastic Leukemia
Carolina Simioni et al.
CELLS (2019)
Knockdown of the CXCL12/CXCR7 chemokine pathway results in learning deficits and neural progenitor maturation impairment in mice
Francoise Trousse et al.
BRAIN BEHAVIOR AND IMMUNITY (2019)
OBI-3424, a Novel AKR1C3-Activated Prodrug, Exhibits Potent Efficacy against Preclinical Models of T-ALL
Kathryn Evans et al.
CLINICAL CANCER RESEARCH (2019)
Hematopoietic stem cells: self-renewal and expansion
Zhenrui Li et al.
CURRENT OPINION IN HEMATOLOGY (2019)
Bortezomib for the Treatment of Hematologic Malignancies: 15 Years Later
Pawel Robak et al.
DRUGS IN R&D (2019)
Exosomal miRNA in chemoresistance, immune evasion, metastasis and progression of cancer
Bhagyashri Kulkarni et al.
DRUG DISCOVERY TODAY (2019)
Overexpression of heme oxygenase-1 in microenvironment mediates vincristine resistance of B-cell acute lymphoblastic leukemia by promoting vascular endothelial growth factor secretion
Kunlin Yu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Antileukemia Effects of Notch-Mediated Inhibition of Oncogenic PLK1 in B-Cell Acute Lymphoblastic Leukemia
Sankaranarayanan Kannan et al.
MOLECULAR CANCER THERAPEUTICS (2019)
T-cell acute lymphoblastic leukemia displays autocrine production of Interleukin-7
Anne Buffiere et al.
ONCOGENE (2019)
Spotlight on Bortezomib: potential in the treatment of hepatocellular carcinoma
I-Tao Huang et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2019)
Molecular High-Grade B-Cell Lymphoma: Defining a Poor-Risk Group That Requires Different Approaches to Therapy
Chulin Sha et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Continuing challenges and current issues in acute lymphoblastic leukemia
Ankit Kansagra et al.
LEUKEMIA & LYMPHOMA (2018)
CCL3 augments tumor rejection and enhances CD8(+) T cell infiltration through NK and CD103(+) dendritic cell recruitment via IFN
Frederick Allen et al.
ONCOIMMUNOLOGY (2018)
Oxidative stress in normal hematopoietic stem cells and leukemia
Azin Samimi et al.
APMIS (2018)
T cell acute lymphoblastic leukemia (T-ALL): New insights into the cellular origins and infiltration mechanisms common and unique among hematologic malignancies
Eduardo Vadillo et al.
BLOOD REVIEWS (2018)
Targeting the microenvironment in solid tumors
Carmen Belli et al.
CANCER TREATMENT REVIEWS (2018)
Blood Development: Hematopoietic Stem Cell Dependence and Independence
Elaine Dzierzak et al.
CELL STEM CELL (2018)
Role of CXCL12 and CXCR4 in the pathogenesis of hematological malignancies
Amnon Peled et al.
CYTOKINE (2018)
Characterization of a new B-ALL cell line with constitutional defect of the Notch signaling pathway
Paul Takam Kamga et al.
Oncotarget (2018)
The safety of bortezomib for the treatment of multiple myeloma
Guldane Cengiz Seval et al.
EXPERT OPINION ON DRUG SAFETY (2018)
Immune cell subset differentiation and tissue inflammation
Pu Fang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Cancer stem cells as key drivers of tumour progression
Ain Zubaidah Ayob et al.
JOURNAL OF BIOMEDICAL SCIENCE (2018)
Chemoresistance of Cancer Cells: Requirements of Tumor Microenvironment-mimicking In Vitro Models in Anti-Cancer Drug Development
Yeonho Jo et al.
THERANOSTICS (2018)
Hyper-CVAD plus nelarabine in newly diagnosed adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma
Yasmin Abaza et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
Bortezomib for treatment of therapy-refractory anti-NMDA receptor encephalitis
Franziska Scheibe et al.
NEUROLOGY (2017)
Nelarabine in the treatment of pediatric and adult patients with T-cell acute lymphoblastic leukemia and lymphoma
Tapan M. Kadia et al.
EXPERT REVIEW OF HEMATOLOGY (2017)
Combination of bortezomib and daunorubicin in the induction of apoptosis in T-cell acute lymphoblastic leukemia
Xin Du et al.
MOLECULAR MEDICINE REPORTS (2017)
Interleukin-7 signaling as a therapeutic target in acute lymphoblastic leukemia
Angela Maria Savino et al.
EXPERT REVIEW OF HEMATOLOGY (2017)
The hypoxia signalling pathway in haematological malignancies
Marta Irigoyen et al.
ONCOTARGET (2017)
Quantifying the effects of antiangiogenic and chemotherapy drug combinations on drug delivery and treatment efficacy
Sirin Yonucu et al.
PLOS COMPUTATIONAL BIOLOGY (2017)
Bortezomib in Kidney Transplant: Current Use and Perspectives
Lucio R. Requiao-Moura et al.
CURRENT DRUG METABOLISM (2017)
Anti-leukemic activity of bortezomib and carfilzomib on B-cell precursor ALL cell lines
Kazuya Takahashi et al.
PLOS ONE (2017)
The proteasome and proteasome inhibitors in multiple myeloma
Sara Gandolfi et al.
CANCER AND METASTASIS REVIEWS (2017)
Intein-mediated site-specific synthesis of tumor-targeting protein delivery system: Turning PEG dilemma into prodrug-like feature
Yingzhi Chen et al.
BIOMATERIALS (2017)
A phase I study of carfilzomib for relapsed or refractory acute myeloid and acute lymphoblastic leukemia
Lukas D. Wartman et al.
LEUKEMIA & LYMPHOMA (2016)
Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: From biology to therapeutic targeting
Francesca Chiarini et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2016)
The role of bortezomib in the treatment of acute lymphoblastic leukemia
Mohammad Faizan Zahid
FUTURE ONCOLOGY (2016)
Optimal interleukin-7 receptor-mediated signaling, cell cycle progression and viability of T-cell acute lymphoblastic leukemia cells rely on casein kinase 2 activity
Alice Melao et al.
HAEMATOLOGICA (2016)
Microenvironmental cues for T-cell acute lymphoblastic leukemia development
Diana Passaro et al.
IMMUNOLOGICAL REVIEWS (2016)
Improving nelarabine efficacy in T cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway
Annalisa Lonetti et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
The expression and function of E3 ligase SIAH2 in acute T lymphoblastic leukemia
Hongxia Chen et al.
LEUKEMIA RESEARCH (2016)
Lineage switch with t(6;11)(q27;q23) from T-cell lymphoblastic lymphoma to acute monoblastic leukemia at relapse
Yusuke Higuchi et al.
CANCER GENETICS (2016)
Optimal interleukin-7 receptor-mediated signaling, cell cycle progression and viability of T-cell acute lymphoblastic leukemia cells rely on casein kinase 2 activity
Alice Melao et al.
HAEMATOLOGICA (2016)
AKR1C3 is a biomarker of sensitivity to PR-104 in preclinical models of T-cell acute lymphoblastic leukemia
Donya Moradi Manesh et al.
BLOOD (2015)
Leukemia stem cells in T-ALL require active Hif1α and Wnt signaling
Vincenzo Giambra et al.
BLOOD (2015)
CXCL12-Producing Vascular Endothelial Niches Control Acute T Cell Leukemia Maintenance
Lauren A. Pitt et al.
CANCER CELL (2015)
CXCL12/CXCR4 axis in the pathogenesis of acute lymphoblastic leukemia (ALL): a possible therapeutic target
Aparecida de Lourdes Perim et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2015)
Integrated methylome and transcriptome analysis reveals novel regulatory elements in pediatric acute lymphoblastic leukemia
Md Almamun et al.
EPIGENETICS (2015)
Molecular effects of the phosphatidylinositol-3-kinase inhibitor NVP-BKM120 on T and B-cell acute lymphoblastic leukaemia
Joao Kleber Novais Pereira et al.
EUROPEAN JOURNAL OF CANCER (2015)
Activated Notch counteracts Ikaros tumor suppression in mouse and human T-cell acute lymphoblastic leukemia
M. T. Witkowski et al.
LEUKEMIA (2015)
The novel dual PI3K/mTOR inhibitor NVP-BGT226 displays cytotoxic activity in both normoxic and hypoxic hepatocarcinoma cells
Carolina Simioni et al.
ONCOTARGET (2015)
Triple Akt inhibition as a new therapeutic strategy in T-cell acute lymphoblastic leukemia
Alice Cani et al.
ONCOTARGET (2015)
Maintenance chemotherapy in children with ALL exerts metronomic-like thrombospondin-1 associated anti-endothelial effect
Nicolas Andre et al.
ONCOTARGET (2015)
Alpha2beta1 integrin promotes T cell survival and migration through the concomitant activation of ERK/Mcl-1 and p38 MAPK pathways
Dalila Naci et al.
CELLULAR SIGNALLING (2014)
The Role of Hypoxia and Exploitation of the Hypoxic Environment in Hematologic Malignancies
Barbara Muz et al.
MOLECULAR CANCER RESEARCH (2014)
Targeting the PI3K/Akt/mTOR signaling pathway in B-precursor acute lymphoblastic leukemia and its therapeutic potential
L. M. Neri et al.
LEUKEMIA (2014)
Role of tumour angiogenesis in haematological malignancies
Michael Medinger et al.
SWISS MEDICAL WEEKLY (2014)
CXCL12 modulation of CXCR4 and CXCR7 activity in human glioblastoma stem-like cells and regulation of the tumor microenvironment
Roberto Wuerth et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
Activity of the novel mTOR inhibitor Torin-2 in B-precursor acute lymphoblastic leukemia and its therapeutic potential to prevent Akt reactivation
Carolina Simioni et al.
ONCOTARGET (2014)
Microenvironment-mediated resistance to anticancer therapies
Oakley C. Olson et al.
CELL RESEARCH (2013)
Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases
Masabumi Shibuya
JOURNAL OF BIOCHEMISTRY (2013)
Notch1 is required for hypoxia-induced proliferation, invasion and chemoresistance of T-cell acute lymphoblastic leukemia cells
Jie Zou et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2013)
Regulation of HIF-1α signaling and chemoresistance in acute lymphocytic leukemia under hypoxic conditions of the bone marrow microenvironment
Olga Frolova et al.
CANCER BIOLOGY & THERAPY (2012)
Cytotoxic activity of the novel Akt inhibitor, MK-2206, in T-cell acute lymphoblastic leukemia
C. Simioni et al.
LEUKEMIA (2012)
Endothelial and perivascular cells maintain haematopoietic stem cells
Lei Ding et al.
NATURE (2012)
Notch-3 and Notch-4 signaling rescue from apoptosis human B-ALL cells in contact with human bone marrow-derived mesenchymal stromal cells
Armel Herve Nwabo Kamdje et al.
BLOOD (2011)
Phosphorylated CXCR4 Is Associated With Poor Survival in Adults With B-Acute Lymphoblastic Leukemia
Sergej Konoplev et al.
CANCER (2011)
Human Solid Tumors Contain High Endothelial Venules: Association with T- and B-Lymphocyte Infiltration and Favorable Prognosis in Breast Cancer
Ludovic Martinet et al.
CANCER RESEARCH (2011)
Targeting HIF1α Eliminates Cancer Stem Cells in Hematological Malignancies
Yin Wang et al.
CELL STEM CELL (2011)
Rapid mobilization of hematopoietic progenitors by AMD3100 and catecholamines is mediated by CXCR4-dependent SDF-1 release from bone marrow stromal cells
A. Dar et al.
LEUKEMIA (2011)
Hypoxia-inducible factor-1α protein expression is associated with poor survival in normal karyotype adult acute myeloid leukemia
George Deeb et al.
LEUKEMIA RESEARCH (2011)
Pronounced Hypoxia in Models of Murine and Human Leukemia: High Efficacy of Hypoxia-Activated Prodrug PR-104
Juliana Benito et al.
PLOS ONE (2011)
Increased CCL2 and IL-8 in the Bone Marrow Microenvironment in Acute Lymphoblastic Leukemia
Jaira Ferreira de Vasconcellos et al.
PEDIATRIC BLOOD & CANCER (2011)
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
Kai Kessenbrock et al.
CELL (2010)
CXCR7: a new SDF-1-binding receptor in contrast to normal CD34+progenitors is functional and is expressed at higher level in human malignant hematopoietic cells
Maciej Tarnowski et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
The cancer stem cell paradigm: a new understanding of tumor development and treatment
Johnathan D. Ebben et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2010)
Mesenchymal and haematopoietic stem cells form a unique bone marrow niche
Simon Mendez-Ferrer et al.
NATURE (2010)
Self-Renewal of Acute Lymphocytic Leukemia Cells Is Limited by the Hedgehog Pathway Inhibitors Cyclopamine and IPI-926
Tara L. Lin et al.
PLOS ONE (2010)
The Emerging Role of the Phosphatidylinositol 3-Kinase/ Akt/Mammalian Target of Rapamycin Signaling Network in Cancer Stem Cell Biology
Alberto M. Martelli et al.
Cancers (2010)
Aberrant regulation of pVHL levels by microRNA promotes the HIF/VEGF axis in CLL B cells
Asish K. Ghosh et al.
BLOOD (2009)
Regulation of Oxygen Homeostasis by Hypoxia-Inducible Factor 1
Gregg L. Semenza
PHYSIOLOGY (2009)
Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-κB and JNK/AP-1 pathways
Maria T. Scupoli et al.
HAEMATOLOGICA (2008)
Stem cell niche: Microenvironment and beyond
Jiwang Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Mechanism of action and preclinical antitumor activity of the novel hypoxia-activated DNA cross-linking agent PR-104
Adam V. Patterson et al.
CLINICAL CANCER RESEARCH (2007)
CXCR4 antagonists mobilize childhood acute lymphoblastic leukemia cells into the peripheral blood and inhibit engraftment
J. Juarez et al.
LEUKEMIA (2007)
Interaction of interleukin-7 and interleukin-3 with the CXCL12-induced proliferation of B-cell progenitor acute lymphoblastic leukemia
Julius Juarez et al.
HAEMATOLOGICA (2007)
Interleukin 7 requirement for survival of T-cell acute lymphoblastic leukemia and human thymocytes on bone marrow stroma
Maria T. Scupoli et al.
HAEMATOLOGICA (2007)
IL-7 induces myelopoiesis and erythropoiesis
Francesca B. Aiello et al.
JOURNAL OF IMMUNOLOGY (2007)
Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches
Tatsuki Sugiyama et al.
IMMUNITY (2006)
Leukemia-stimulated bone marrow endothelium promotes leukemia cell survival
J. Pedro Veiga et al.
EXPERIMENTAL HEMATOLOGY (2006)
Phase II study of nelarabine (compound 506U78) in children and young adults with refractory T-Cell malignancies: A report from the children's oncology group
SL Berg et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
The role of the tumor microenvironment in hematological malignancies and implication for therapy
JB Zhou et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2005)
Vascular endothelial growth factor and angiogenesis
A Hoeben et al.
PHARMACOLOGICAL REVIEWS (2004)
Activation of the HIF pathway in childhood ALL, prognostic implications of VEGF
S Wellmann et al.
LEUKEMIA (2004)
The biology of VEGF and its receptors
N Ferrara et al.
NATURE MEDICINE (2003)
Autocrine-paracrine VEGF loops potentiate the maturation of megakaryocytic precursors through Flt1 receptor
I Casella et al.
BLOOD (2003)
Enhanced T-lineage acute lymphoblastic leukaemia cell survival on bone marrow stroma requires involvement of LFA-1 and ICAM-1
SS Winter et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Clinical importance of serum vascular endothelial and basic fibroblast growth factors in children with acute lymphoblastic leukemia
S Yetgin et al.
LEUKEMIA & LYMPHOMA (2001)
Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells
K Hattori et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Chemokines and lymphopoiesis in human thymus
F Annunziato et al.
TRENDS IN IMMUNOLOGY (2001)
Characterization of cytokine, growth factor receptor, costimulatory and adhesion molecule expression patterns of bone marrow blasts in relapsed childhood B cell precursor ALL
C Kebelmann-Betzing et al.
CYTOKINE (2001)
分享论文
